These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3938803)

  • 1. A one-compartment model for calcium oxalate tissue deposition during xylitol infusions in humans.
    Conyers RA; Huber TW; Thomas DW; Rofe AM; Bais R; Edwards RG
    Int J Vitam Nutr Res Suppl; 1985; 28():47-57. PubMed ID: 3938803
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acute kidney failure in secondary renal oxalosis. Additional indications for a causal connection to xylitol infusions].
    Schultze G; Pommer W; Offermann G; Molzahn M; Butz M; Krause PH; Lobeck H; Tschöpe W
    Infusionsther Klin Ernahr; 1983 Dec; 10(6):322-8. PubMed ID: 6420342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxalate-induced encephalitic reactions to polyol-containing infusions during intensive care.
    Peiffer J; Danner E; Schmidt PF
    Clin Neuropathol; 1984; 3(2):76-87. PubMed ID: 6424993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of oxalate in pyridoxine or thiamin deficient rats during intravenous xylitol infusions.
    Hannett B; Thomas DW; Chalmers AH; Rofe AM; Edwards JB; Edwards RG
    J Nutr; 1977 Mar; 107(3):458-65. PubMed ID: 845682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal cerebro-renal oxalosis after appendectomy.
    Pfeiffer H; Weiss FU; Karger B; Aghdassi A; Lerch MM; Brinkmann B
    Int J Legal Med; 2004 Apr; 118(2):98-100. PubMed ID: 14634832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary renal oxalosis. A statistical analysis of its possible causes.
    Mori S; Beppu T
    Acta Pathol Jpn; 1983 Jul; 33(4):661-9. PubMed ID: 6624448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of parenterally infused xylitol during labor and after surgery].
    Ackermann RH
    Infusionsther Klin Ernahr; 1980 Jun; 7(3):113-5. PubMed ID: 7191831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Xylitol and blood-brain barrier].
    Opitz K; Lutz M
    Z Ernahrungswiss Suppl; 1971; 11():39-43. PubMed ID: 5290593
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on xylitol metabolism].
    Halmagyi M
    Z Ernahrungswiss Suppl; 1971; 11():17-9. PubMed ID: 5290590
    [No Abstract]   [Full Text] [Related]  

  • 10. [Xylitol balance during long-term infusions with constant amounts in healthy men].
    Heuckenkamp PU; Zöllner N
    Klin Wochenschr; 1972 Nov; 50(22):1063-5. PubMed ID: 4637663
    [No Abstract]   [Full Text] [Related]  

  • 11. [Infusion velocity and tolerance of xylitol solution].
    Igarashi T; Shoji T; Yamamoto H; Tanabe Y; Miyakawa T; Nakajima Y; Kobayashi M
    Z Ernahrungswiss Suppl; 1971; 11():20-8. PubMed ID: 5290592
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on oxalate in urolithiasis. III. Effect of xylitol infusion on plasma and urinary oxalate (author's transl)].
    Ogawa Y
    Nihon Hinyokika Gakkai Zasshi; 1981 Dec; 72(12):1553-8. PubMed ID: 7345193
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolic and hormonal effects of xylitol in man.
    Rubenstein AH; Spitz I; Bersohn I
    Z Ernahrungswiss Suppl; 1971; 11():44-8. PubMed ID: 5290594
    [No Abstract]   [Full Text] [Related]  

  • 14. Limited role of endogenous glycolate as oxalate precursor in xylitol-infused patients.
    Bär A; Löhlein D
    Contrib Nephrol; 1987; 58():160-3. PubMed ID: 3121252
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy-induced cerebro-renal oxalosis?].
    Bergmann M; Silling-Engelhardt G; Schnabel R; Gulotta F
    Z Gesamte Inn Med; 1991 Mar; 46(4):101-6. PubMed ID: 1905442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolic investigations during and after infusions of glucose and other sugars (author's transl)].
    Förster H; Zagel D
    Dtsch Med Wochenschr; 1974 Jun; 99(24):1300-4. PubMed ID: 4843422
    [No Abstract]   [Full Text] [Related]  

  • 17. [Metabolic investigations during continuous infusion of glucose, fructose, and xylitol over 48 hours (author's transl)].
    Förster H; Heller L; Hellmund U
    Dtsch Med Wochenschr; 1974 Aug; 99(35):1723-9. PubMed ID: 4212704
    [No Abstract]   [Full Text] [Related]  

  • 18. Oxalate excretion during carbohydrate infusions.
    Thomas DW; Hannett B; Chalmers A; Rofe AM; Edwards JB; Edwards RG
    Int Z Vitam Ernahrungsforsch Beih; 1976; 15():181-92. PubMed ID: 1066329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism of serum uric acid increase during continuous xylitol infusions].
    Kaiser W; Stocker K; Heuckenkamp PU
    Infusionstherapie (1973); 1974 Oct; 1(7):548-50. PubMed ID: 4219390
    [No Abstract]   [Full Text] [Related]  

  • 20. The metabolic production of oxalate from xylitol.
    Conyers RA; Rofe AM; Bais R; James HM; Edwards JB; Thomas DW; Edwards RG
    Int J Vitam Nutr Res Suppl; 1985; 28():9-28. PubMed ID: 3938807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.